Angitia Biopharmaceuticals Announces $120 Million Series C Financing
11 déc. 2024 08h00 HE
|
Angitia Incorporated Limited
- Financing led by Bain Capital Life Sciences with significant participation from existing and new investors - Proceeds will support the development of AGA2118, AGA2115, AGA111 and other pipeline...
Acuitive Technologies Receives FDA 510(k) Clearance for CITREPORE™, A New Synthetic Bioactive Bone Void Filler for Orthopedic Procedures
12 nov. 2024 08h00 HE
|
Acuitive Technologies
Acuitive Technologies announced the FDA 510(k) clearance of CITREPORE™, a new synthetic bioactive bone void filler for orthopedic procedures.
Globus Medical Reports Third Quarter 2024 Results
05 nov. 2024 16h15 HE
|
Globus Medical
AUDUBON, Pa., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended...
Angitia Biopharmaceuticals Announces Dosing of First Patient in Phase 2 Clinical Trial of AGA2118 for the Treatment of Osteoporosis
04 nov. 2024 07h30 HE
|
Angitia Incorporated Limited
WOODLAND HILLS, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Angitia Biopharmaceuticals, a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for...
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
15 oct. 2024 16h30 HE
|
Globus Medical
AUDUBON, Pa., Oct. 15, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the third quarter ended...
Angitia Biopharmaceuticals to Present Data on AGA2118 for Osteoporosis at ASBMR 2024
16 sept. 2024 07h30 HE
|
Angitia Biopharmaceuticals
Angitia announces multiple presentations at ASBMR.
Accarent Health Announces Affiliation with Cleveland Clinic to Provide Bariatric, Orthopedic, and Spine Services
21 août 2024 10h57 HE
|
Accarent Health
Baltimore, MD, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Accarent Health has announced a new affiliation with Cleveland Clinic, which is recognized in the United States and throughout the world for its...
Globus Medical Reports Second Quarter 2024 Results
06 août 2024 16h15 HE
|
Globus Medical
AUDUBON, Pa., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended June 30,...
Globus Medical Receives FDA 510(k) Clearance for ExcelsiusFlex™ and ACTIFY™ 3D Total Knee System
17 juil. 2024 08h30 HE
|
Globus Medical
AUDUBON, Pa., July 17, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced it recently received 510(k) clearance by the U.S. Food...
Globus Medical Schedules Second Quarter Earnings Release and Conference Call
16 juil. 2024 16h30 HE
|
Globus Medical
AUDUBON, Pa., July 16, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended June...